Viladés Consuelo, Broch Montserrat, Plana Montserrat, Domingo Pere, Alonso-Villaverde Carlos, Pedrol Enric, Knobel Hernando, Dalmau David, Peraire Joaquim, Gutiérrez Cristina, López Anna, Sambeat Maria Antònia, Olona Montserrat, Garcia Felipe, Richart Cristóbal, Gatell Josep Maria, Vidal Francesc
Department of Internal Medicine, Infectious Diseases and AIDS Research unit, Hospital Universitari de Tarragona Joan XXIII and Universitat Rovira i Virgili, Tarragona, Spain.
J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):132-8. doi: 10.1097/QAI.0b013e31802b3147.
Polymorphisms in the genes that encode for the CCR2 chemokine receptor and its natural ligand CCL2 have been shown to influence the natural history of HIV-1 infection, although data are inconsistent. Our aim was to determine whether functionally active CCR2 and CCL2 genetic variants influence the risk of infection and disease progression in a cohort of white Spaniards.
This was a multicenter genetic association case-control study. Two single nucleotide polymorphisms (SNPs), V64I (G > A) of the CCR2 gene and -2518 (A > G) of the CCL2 gene, were assessed in 318 individuals: 73 HIV-1-infected long-term nonprogressors (LTNPs) of >16 years duration, 109 HIV-1-infected usual progressors (UPs), 36 heavily exposed to HIV-1 but uninfected individuals (EUs), and 100 control subjects. The distribution of the CCR5Delta32 allele was also assessed. Genotyping was performed using polymerase chain reaction (PCR) restriction fragment length polymorphisms (RFLPs) or PCR and automatic sequencing analysis methods on white blood cell DNA. Genotype and allele frequencies were compared by the chi2 test and the Fisher exact test.
CCR2 genotype distribution and allele frequencies showed nonsignificant differences between groups. The distribution of CCL2 alleles showed no significant differences between groups. HIV-1-infected individuals had, however, a significantly higher prevalence of the variant homozygous CCL2 GG genotype compared with EUs (P = 0.02). This result persisted when we studied only individuals with wild-type CCR5. Genotype and allele distribution of CCL2 was similar in HIV-1-infected UPs and LTNPs.
In our cohort of white Spaniards, homozygosity for the variant CCL2-2518GG genotype is overrepresented in HIV-1-infected subjects.
编码CCR2趋化因子受体及其天然配体CCL2的基因多态性已被证明会影响HIV-1感染的自然病程,尽管数据并不一致。我们的目的是确定功能活跃的CCR2和CCL2基因变异是否会影响一组西班牙白人队列中的感染风险和疾病进展。
这是一项多中心基因关联病例对照研究。在318名个体中评估了CCR2基因的两个单核苷酸多态性(SNP),即V64I(G>A)和CCL2基因的-2518(A>G):73名感染HIV-1超过16年的长期不进展者(LTNP),109名感染HIV-1的普通进展者(UP),36名高度暴露于HIV-1但未感染的个体(EU),以及100名对照受试者。还评估了CCR5Delta32等位基因的分布。使用聚合酶链反应(PCR)限制性片段长度多态性(RFLP)或PCR及自动测序分析方法对白细胞DNA进行基因分型。通过卡方检验和Fisher精确检验比较基因型和等位基因频率。
CCR2基因型分布和等位基因频率在各组之间无显著差异。CCL2等位基因的分布在各组之间也无显著差异。然而,与EU相比,感染HIV-1的个体中变异纯合CCL2 GG基因型的患病率显著更高(P = 0.02)。当我们仅研究具有野生型CCR5的个体时,这一结果仍然存在。CCL2的基因型和等位基因分布在感染HIV-1的UP和LTNP中相似。
在我们的西班牙白人队列中,变异CCL2 - 2518GG基因型的纯合性在感染HIV-1的受试者中比例过高。